/Equities/XLON/AG99

GlaxoSmithKline Capital PLC

Bond

/Equities/XLON/AG99

GlaxoSmithKline Capital PLC

Bond

/Equities/XLON/AG99

Bond

/Equities/XLON/AG99

GlaxoSmithKline Capital PLC

Bond

Loading price data...

--

Recent RNS announcements

28 Apr 2026	16:56:06	Annual Financial Report
30 Jul 2025	16:45:49	Half-year Report
29 Apr 2025	15:45:01	Annual Financial Report
31 Jul 2024	16:03:55	Half-year Report
30 Apr 2024	09:36:07	Annual Financial Report

Annual Reports

29 Apr 2025	Annual Financial Report
30 Apr 2024	Annual Financial Report
28 Apr 2023	Financial Results

Directors (20+)

Sir Jonathan Symonds, CBEChair

–

Luke MielsChief Executive Officer

–

Julie Belita BrownChief Financial Officer

3 yrs 2 mos

Dr Tony WoodChief Scientific Officer

–

Shobie RamakrishnanChief Digital and Technology Officer

–

Company details

LEI: 549300U0LV41VX7LEP38
Issuer: GlaxoSmithKline Capital PLC
Website: www.gsk.com

Shares details

Shares in issue: —

Instrument details

ISIN: XS0140516864
Exchange: —
Market: Main Market

Loading price data...

--

Recent RNS announcements

28 Apr 2026	16:56:06	Annual Financial Report
30 Jul 2025	16:45:49	Half-year Report
29 Apr 2025	15:45:01	Annual Financial Report
31 Jul 2024	16:03:55	Half-year Report
30 Apr 2024	09:36:07	Annual Financial Report

Annual Reports

29 Apr 2025	Annual Financial Report
30 Apr 2024	Annual Financial Report
28 Apr 2023	Financial Results

Directors (20+)

Sir Jonathan Symonds, CBEChair

–

Luke MielsChief Executive Officer

–

Julie Belita BrownChief Financial Officer

3 yrs 2 mos

Dr Tony WoodChief Scientific Officer

–

Shobie RamakrishnanChief Digital and Technology Officer

–

Company details

LEI: 549300U0LV41VX7LEP38
Issuer: GlaxoSmithKline Capital PLC
Website: www.gsk.com

Shares details

Shares in issue: —

Instrument details

ISIN: XS0140516864
Exchange: —
Market: Main Market